Czechia – Immunosuppressive agents – Ixekizumab
Opportunity Score
Confidence: 50%
Complexity: low
28 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Tender for the supply of Ixekizumab (immunosuppressive agent) to Ústřední vojenská nemocnice – Vojenská fakultní nemocnice Praha (Czechia). Single lot, open procedure, 48-month framework-like contract (not a framework agreement) with estimated value 7,647,112.80 CZK. Award based solely on lowest price. Submission deadline 2026-07-13. Documents available via NEN profil.
Strengths
Documents available
Open procedure
Low complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Open procedure, electronic submission required via NEN profil.
- Submission languages: Czech (CES) and Slovak (SLK).
- Deadline for tenders: 2026-07-13 08:00 (CEST).
Award Criteria
Nabídková cena
Nejnižší nabídková cena
| Criterion | Type |
|---|---|
Nabídková cena Nejnižší nabídková cena | Price |
Buyer
Name
Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha
Location
Praha - Břevnov, CZE
Buyer profile
Identifier
61383082
Lots (1)
Continuous supply of medicinal product with active substance Ixekizumab for the hospital's needs over 48 months.
Procurement Details
Publication
09 Jun 2026
Deadline
13 Jul 2026, 08:00
Procedure
open
Contract
supplies
Duration
48 MONTH
Language
CES, SLK
Publication #
396332-2026
Classification
Performance: Czech Republic
Documents (2)
Opportunity Score
Confidence: 50%
Complexity: low
28 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation